CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Enhancing Host Cell DNA Testing With Digital PCR

  Residual host cell DNA testing is evolving with digital PCR. Discover how streamlined methods improve accuracy, minimize manual steps, and support efficient biopharmaceutical manufacturing processes.

• Bio-Based Polymers Towards Net Zero In Single-Use Bioprocessing

  Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.

• Innovation In Filtration

  Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.

• Engineering Reliability In Cell Therapy Manufacturing

  A cell therapy manufacturing model built on precision planning, digital execution, lifecycle‑ready CMC systems, and transparent collaboration to achieve high reliability and reduce variability across programs.

• Expansion Of Human Umbilical Cord-Derived MSCs

  Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.

• Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies

  Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.

• Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer

  When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.

• Mild pH Protein A Purification Step With A Mild Elution Resin

  As antibody formats diversify, low-pH protein A elution can drive aggregation and yield loss. Learn how milder elution conditions during capture can help protect sensitive molecules and ease challenges.

• Manufacturing of "MSC 2.0" Using Functionally Closed Systems

  Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor.

• USP <665> Becomes Official On May 1, 2026. Are You Ready?

  With USP <665> becoming official on May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.